Thus, lower secretion of both HGF and FGF10 could contribute to the abnormalities observed in LMSC-supported organoid formation, while leaving cytoprotective effects and support of wound healing responses by COPD-derived LMSCs intact. Here, FGF10 is linked to chronic obstructive pulmonary disease.